미생물 발효 기술 시장 규모는 2024년에 305억 6,000만 달러로 평가되었고, 2026-2032년 5%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 451억 4,000만 달러에 달할 것으로 예측됩니다.
미생물 발효 기술은 특정 환경 조건에서 박테리아, 효모, 곰팡이 등의 미생물을 제어하여 가치 있는 상품을 생산하는 기술입니다. 미생물의 대사 능력을 이용하여 생화학 반응을 이용하여 원료를 원하는 분자로 변환합니다. 발효는 미생물과 원하는 결과에 따라 호기성(산소 있음) 또는 혐기성(산소 없음) 조건에서 이루어집니다. 이 기술은 원래 식음료 제조에 이용되었으나, 이후 의약품, 화학물질, 바이오연료, 생분해성 플라스틱으로까지 발전했습니다.
이 방법은 다양한 산업에서 광범위하게 사용되고 있습니다. 요구르트, 치즈, 빵과 같은 발효 식품의 제조에 중요한 역할을 합니다. 제약 산업에서는 항생제, 백신, 치료용 단백질의 제조에 사용됩니다. 화학 산업에서 발효는 유기산, 효소, 아미노산을 생성하여 다양한 제품에 활용되고 있습니다.
미생물 발효 시장의 대폭적인 확대와 혁신. 유전공학과 합성생물학의 발전은 미생물 균주를 진화시키고, 특정 제품에 최적화하는 능력을 향상시키고, 생산과 효율성을 향상시키고 있습니다. 지속가능한 관행과 순환 경제로의 전환은 특히 바이오 제품 및 재생 가능 에너지 원에 대한 미생물 발효의 추가 연구 개발에 박차를 가할 것으로 예측됩니다.
세계 미생물 발효 기술 시장을 형성하는 주요 시장 역학
주요 시장 성장 촉진요인
바이오 제품에 대한 수요 증가 미생물 발효 기술 시장은 지속가능한 천연 제품에 대한 고객 수요 증가에 힘입어 성장하고 있습니다. 미국 농무부 보고서에 따르면, 세계 바이오 제품 시장은 2024년까지 4,872억 달러에 달할 것으로 예측됩니다.
음료 및 식품 산업에서의 채택 증가: 미생물 발효는 특히 프로바이오틱스 및 발효 식품 제조와 같은 음료 및 식품 산업에서 광범위하게 채택되고 있습니다. 국제 프로바이오틱스 협회는 세계 프로바이오틱스 시장이 2023년까지 693억 달러에 달할 것으로 예상하며, 2018년부터 2023년까지 연평균 7.0%의 성장률을 보일 것으로 전망하고 있습니다.
제약 산업에서의 응용 확대: 미생물 발효는 항생제, 효소 등 의약품 생산에 점점 더 많이 사용되고 있습니다. 세계보건기구(WHO)에 따르면, 세계 항생제 산업은 2025년까지 503억 7,000만 달러 규모에 달할 것으로 예상되며, 발효 기술이 생산량의 상당 부분을 차지할 것으로 예측됩니다.
주요 과제
공정 최적화 및 스케일업 주요 과제 중 하나는 생산성, 순도, 효율성을 최적화하기 위한 발효 작업의 최적화입니다. 실험실 규모에서 산업 규모로 생산 규모를 확대하려면 안정된 환경 조건 유지, 무균성 확보, 발효 동역학 제어와 같은 기술적 문제를 해결해야 하는 경우가 많습니다. 원료와 미생물 균주의 편차도 스케일업의 걸림돌로 작용하기 때문에 많은 연구개발비가 필요합니다.
제품 다양화와 시장 수요: 새로운 제품과 용도에 대한 다양한 시장 수요를 충족시키기 위해서는 지속적인 기술 혁신과 적응성이 필요합니다. 미생물 발효 기술은 변화하는 고객 요구, 과학적 개선, 환경 목표에 대응해야 합니다. 새로운 미생물 균주 개발, 특정 제품에 맞는 발효 조건 조정, 기존 대체품에 비해 우수한 성능 입증은 모두 시장 타당성과 경쟁력을 높이기 위한 지속적인 과제입니다.
기술 통합 및 디지털화: 발효 공정을 자동화, 인공지능, 빅데이터 분석과 같은 디지털 기술과 통합하는 것은 가능성과 장애물을 모두 만들어 냅니다. 디지털화는 공정 관리, 효율성, 제품 품질을 향상시키지만, 이러한 기술을 성공적으로 통합하기 위해서는 인프라, 경험, 데이터 관리 능력에 대한 막대한 투자가 필요합니다.
주요 동향 :
바이오 의약품의 확대: 미생물 발효는 항체, 백신, 치료용 단백질과 같은 바이오 의약품 생산에 점점 더 많이 사용되고 있습니다. 유전공학 및 바이오프로세스 최적화의 발전으로 더 높은 수율과 저렴한 가격으로 복잡한 화합물을 생산할 수 있게 되어 바이오 의약품 분야에서 미생물 발효의 활용을 촉진하고 있습니다.
지속가능한 바이오 제품의 부상: 환경 지속가능성에 대한 인식이 높아지면서 바이오 제품 시장이 성장하고 있습니다. 미생물 발효는 재생 가능한 원료를 생분해성 고분자, 바이오연료, 친환경 화학 물질로 전환함으로써 표준 화학 합성 공정에 대한 지속가능한 대안을 제공합니다. 친환경 제품에 대한 소비자의 선호와 바이오 경제의 발전을 촉진하는 규제적 인센티브가 이러한 추세를 촉진하고 있습니다.
용도의 다양화: 미생물 발효는 식품이나 의약품과 같은 기성 산업 이외의 새로운 용도를 찾고 있습니다. 농업, 화장품, 섬유, 바이오에너지 산업은 효소, 기호품, 향료, 바이오 농약, 바이오 비료를 생산하기 위해 미생물 발효에 점점 더 많이 의존하고 있습니다. 이러한 다양성은 미생물 발효의 다용도성과 산업계의 요구에 맞게 제품을 조정할 수 있는 능력에 의해 촉진되고 있습니다.
Microbial Fermentation Technology Market size was valued at USD 30.56 Billion in 2024 and is projected to reach USD 45.14 Billion by 2032, growing at a CAGR of 5% from 2026 to 2032.
Microbial fermentation technology is the controlled development of microorganisms such as bacteria, yeast, or fungi under specified environmental conditions to produce valuable goods. It uses the metabolic capabilities of these microorganisms to convert raw materials into desired molecules using biochemical reactions. Fermentation can take place in either aerobic (with oxygen) or anaerobic (without oxygen) conditions, depending on the microbe and desired result. This technology was originally utilized for food and beverage production, but it has since grown to include medications, chemicals, biofuels, and even biodegradable plastics.
This method is used extensively in a variety of industries. It plays an important role in the manufacture of fermented foods such as yogurt, cheese, and bread. In the pharmaceutical industry, it is used to create antibiotics, vaccines, and therapeutic proteins. Fermentation in the chemical industry yields organic acids, enzymes, and amino acids, which are employed in a variety of products.
Significant expansion and innovation in the microbial fermentation market. Advances in genetic engineering and synthetic biology are improving our ability to evolve and optimize microbial strains for specific products, hence increasing production and efficiency. The transition to sustainable practices and the circular economy is expected to spur additional research and development in microbial fermentation, particularly for bio-based products and renewable energy sources.
The key market dynamics that are shaping the global microbial fermentation technology market include:
Key Market Drivers:
Growing Demand for Bio-Based Products: The market for microbial fermentation technology is being driven by rising customer demand for sustainable and natural products. According to a US Department of Agriculture report, the global biobased goods market is predicted to reach $487.2 billion by 2024.
Rising Adoption in the Food and Beverage Industry: Microbial fermentation is widely employed in the food and beverage industry, particularly for the manufacture of probiotics and fermented meals. The International Probiotics Association predicts that the global probiotics market will reach $69.3 billion by 2023, expanding at a 7.0% CAGR between 2018 and 2023.
Expanding Applications in the Pharmaceutical Industry: Microbial fermentation is increasingly being used to produce medications such as antibiotics and enzymes. According to the World Health Organization, the worldwide antibiotics industry is expected to be worth $50.37 billion by 2025, with fermentation technologies accounting for a considerable share of output.
Key Challenges:
Process Optimization and Scale-up: One of the main issues is optimizing fermentation operations for optimal productivity, purity, and efficiency. Scaling up production from laboratory to industrial sizes frequently necessitates solving technical challenges such as maintaining stable ambient conditions, assuring sterility, and controlling fermentation kinetics. Variability in raw materials and microbial strains can also hamper scaling efforts, necessitating significant R&D costs.
Product Diversification and Market Demand: Meeting different market needs for new products and applications necessitates ongoing innovation and adaptability. Microbial fermentation technology must keep up with changing customer demands, scientific improvements, and environmental aims. Developing new microbial strains, adjusting fermentation conditions for specific products, and demonstrating superior performance relative to traditional alternatives are all continuous difficulties for market relevance and competitiveness.
Technological Integration and Digitalization: Integrating fermentation processes with digital technologies like automation, artificial intelligence, and big data analytics creates both potential and obstacles. While digitalization can improve process control, efficiency, and product quality, successfully integrating these technologies necessitates significant investment in infrastructure, experience, and data management capabilities.
Key Trends:
Expansion in Biopharmaceuticals: Microbial fermentation is increasingly being used to produce biopharmaceuticals such as antibodies, vaccines, and therapeutic proteins. Advances in genetic engineering and bioprocess optimization allow for the manufacture of complex compounds with higher yields and lower prices, which is boosting the use of microbial fermentation in the biopharmaceutical sector.
Rise of Sustainable and Bio-Based Products: The growing awareness of environmental sustainability is propelling the market toward bio-based products. Microbial fermentation provides a sustainable alternative to standard chemical synthesis processes by converting renewable feedstocks into biodegradable polymers, biofuels, and green chemicals. Consumer preferences for environmentally friendly products, as well as regulatory incentives to promote bioeconomy development, are driving this trend.
Application Diversification: Microbial fermentation is finding new uses outside of established industries like food and pharmaceuticals. Agriculture, cosmetics, textiles, and bioenergy industries are increasingly relying on microbial fermentation to produce enzymes, tastes, perfumes, biopesticides, and biofertilizers. This diversity is fueled by the versatility of microbial fermentation and its capacity to tailor products to suit industrial requirements.
Here is a more detailed regional analysis of the global microbial fermentation technology market:
Asia Pacific:
The Asia Pacific region currently holds the crown for the microbial fermentation technology market. According to UNESCAP, the Asia Pacific region's population is expected to expand rapidly, reaching 4.7 billion by 2050, producing strong demand across a variety of sectors that rely on fermentation technologies. The food and beverage market are primed for tremendous growth.
The region's huge and growing population has resulted in an increase in demand for food and drinks, pharmaceuticals, and industrial enzymes, all of which rely heavily on fermentation.
A growing number of Asian countries are developing as hubs for biopharmaceutical outsourcing, drawing both domestic and foreign firms. This, together with rising disposable income and greater investment in the food and beverage industry, drives the demand for sophisticated fermentation technology.
North America:
North America is expected to be the fastest expanding market for microbial fermentation technologies. North America is seeing a tremendous movement toward sustainable and environmentally friendly products, which is boosting the development of microbial fermentation technological advances. The US Department of Agriculture's bio-preferred program emphasizes the bio-based goods sector's significant economic impact, which contributed $459 billion to the US economy in 2016 and continues to grow.
The National Research Council of Canada predicts that the global market for bio-based chemicals will reach $85.6 billion by 2024, with North America serving as a key driver of this expansion. The findings highlight the region's vital function in developing bio-based solutions using microbial fermentation technologies.
North America leads the way in incorporating precise fermentation processes into food technology. According to the Good Food Institute, North American firms focused on fermentation-enabled alternative proteins raised $1.7 billion in funding in 2021.
The United States Department of Agriculture predicts that by 2030, the global market for alternative proteins, including those obtained from fermentation, will account for 10% of the entire protein industry, representing a $14 billion opportunity. These advancements emphasize North America's critical role in developing the use of precision fermentation to create sustainable and innovative food solutions.
The Global Microbial Fermentation Technology Market is Segmented on the basis of Product Type, Application, And Geography.
Based on Product Type, the market is bifurcated into Enzymes, Antibiotics, Organic Acids, Vitamins, and Biopolymers. Antibiotics dominate the microbial fermentation technology market due to established manufacturing methods and strong demand for these life-saving medications. However, the biopolymers segment is predicted to develop the fastest, owing to the growing emphasis on sustainability and the demand for environmentally acceptable alternatives to standard plastics.
Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Agriculture, Industrial Chemicals, and Environmental. Due to the increasing demand for biopharmaceuticals such as antibiotics, vaccines, and other therapeutic proteins, the pharmaceutical segment now controls the majority of the microbial fermentation industry. However, the food and beverage industry is predicted to grow the fastest, thanks to the increased popularity of fermented goods such as yogurt and kombucha, as well as plant-based alternatives to meat and dairy.
The "Global Microbial Fermentation Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza Group AG, Novozymes A/S, Danone Ltd., Amyris, Inc., Biocon Ltd., TerraVia Holdings, Inc., BioVectra, Inc., and United Breweries Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.